Greenshoe

Chimera Investment Corporation Announces Public Offering of Convertible Senior Notes

Monday, April 6, 2020 - 9:33pm

Chimera Investment Corporation (NYSE: CIM) (the Company) today announced that it has commenced an underwritten public offering of $250.0 million aggregate principal amount of convertible senior notes due 2023 (the Notes), subject to market and other conditions.

Key Points: 
  • Chimera Investment Corporation (NYSE: CIM) (the Company) today announced that it has commenced an underwritten public offering of $250.0 million aggregate principal amount of convertible senior notes due 2023 (the Notes), subject to market and other conditions.
  • The Notes will be senior unsecured obligations of the Company.
  • If the underwriter exercises its over-allotment option, the Company expects to enter into additional capped call transactions with the option counterparties.
  • These forward-looking statements include, but are not limited to, statements regarding the Companys offering of Notes and the use of proceeds from the offering.

WiMi Hologram Cloud Inc. Announces Closing of Underwritten Initial Public Offering

Friday, April 3, 2020 - 10:45pm

BEIJING, April 3, 2020 /PRNewswire/ -- WiMi Hologram Cloud Inc. (Nasdaq: WIMI) ("WiMi" or the"Company"), a leading AR services provider in China, announced the closing of its previously announced underwritten initial public offering of 4,750,000 American Depositary Shares ("ADSs"), each representing two Class B ordinary shares of the Company.

Key Points: 
  • BEIJING, April 3, 2020 /PRNewswire/ -- WiMi Hologram Cloud Inc. (Nasdaq: WIMI) ("WiMi" or the"Company"), a leading AR services provider in China, announced the closing of its previously announced underwritten initial public offering of 4,750,000 American Depositary Shares ("ADSs"), each representing two Class B ordinary shares of the Company.
  • The aggregate gross proceeds to the company from the offering, before deducting underwriting discounts and commission and estimated offering expenses, totaled approximately $26.0 million.
  • As previously announced, the company has granted the underwriters a 30-day over-allotment option to purchase up to 712,500 ADSs at the public offering price, less underwriting discounts and commissions.
  • This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the proposed initial public offering.

SG Blocks Announces Proposed Public Offering of Common Stock

Wednesday, April 1, 2020 - 1:09am

SG Blocks, Inc. (NASDAQ: SGBX ), a leading designer, fabricator and innovator of container-based structures, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Key Points: 
  • SG Blocks, Inc. (NASDAQ: SGBX ), a leading designer, fabricator and innovator of container-based structures, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
  • SG Blocks expects to grant the underwriters a 45-day option to purchase additional shares of common stock offered in the public offering.
  • SG Blocks intends to use the net proceeds from the proposed offering for working capital.
  • This press release contains forward-looking statements regarding the proposed public offering and the intended use of proceeds from the offering.

DGAP-News: Goldsource Closes $6.6 Million Brokered Private Placement, 80% of Over-Allotment Option Exercised

Tuesday, March 24, 2020 - 9:04pm

Goldsource Closes $6.6 Million Brokered Private Placement, 80% of Over-Allotment Option Exercised

Key Points: 
  • Goldsource Closes $6.6 Million Brokered Private Placement, 80% of Over-Allotment Option Exercised
    The issuer is solely responsible for the content of this announcement.
  • Each Unit consisted of one common share of Goldsource ("Common Share") and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant").
  • Each Warrant entitles the holder to acquire one Common Share at an exercise price of $0.16 until September 24, 2022.
  • The completed Offering includes exercise of the agents' over-allotment option for $1,602,909, representing approximately 80% of the over-allotment option to purchase additional Units at $0.11 per Unit.

Safehold Announces Public Offering and Concurrent Private Placement

Tuesday, March 17, 2020 - 8:07pm

Safehold Inc. (NYSE: SAFE) (the "Company") announced today that it has commenced an underwritten public offering to sell 900,000 shares of its common stock.

Key Points: 
  • Safehold Inc. (NYSE: SAFE) (the "Company") announced today that it has commenced an underwritten public offering to sell 900,000 shares of its common stock.
  • The Company intends to grant the underwriters in the offering a 30-day option to purchase up to an additional 135,000 shares of its common stock.
  • Concurrently with the completion of the public offering, Safehold will sell to iStar Inc. (NYSE: STAR) in a private placement, a number of shares of common stock equal to 66% of the total number of shares sold in the offering and the concurrent private placement (excluding any shares sold pursuant to the underwriters' additional purchase option) up to a maximum aggregate purchase price of $80 million, at the public offering price per share and subject to rounding.
  • The Company intends to use the net proceeds from the offering and concurrent private placement to make additional ground lease investments and for general business purposes.

DFP Healthcare Acquisitions Corp. Announces Closing of $230 Million Initial Public Offering

Friday, March 13, 2020 - 4:30pm

DFP Healthcare Acquisitions Corp. (the Company) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full.

Key Points: 
  • DFP Healthcare Acquisitions Corp. (the Company) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full.
  • The Companys sponsor is an affiliate of Deerfield Management Company, L.P., an investment firm focused exclusively on the healthcare industry, and Richard Barasch.
  • The Companys strategy will be to identify, acquire and, after its initial business combination, build, a healthcare or healthcare related business.
  • This press release contains statements that constitute forward-looking statements, including with respect to the Companys initial public offering and search for an initial business combination.

aTyr Pharma Announces Exercise and Closing of Over-Allotment Option in Public Offering

Tuesday, March 10, 2020 - 12:30pm

The option was granted in connection with the public offering of 4,235,294 shares of common stock at a public offering price of $4.25 per share, which closed on February 10, 2020.

Key Points: 
  • The option was granted in connection with the public offering of 4,235,294 shares of common stock at a public offering price of $4.25 per share, which closed on February 10, 2020.
  • The exercise of the over-allotment option brings the total gross proceeds to aTyr to approximately$20.7 million, before deducting underwriting discounts and commissions and other offering expenses payable by aTyr.
  • aTyr anticipates using the net proceeds from the offering for general corporate purposes, including clinical trial expenses, research and development expenses manufacturing expenses, and general and administrative expenses.
  • These forward-looking statements, include statements regarding the anticipated use of net proceeds from the public offering.

Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Friday, March 6, 2020 - 9:05pm

NEWTON, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters option to purchase additional shares.

Key Points: 
  • NEWTON, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters option to purchase additional shares.
  • 7,187,500 shares of the Companys common stock at a price to the public of $24.00 per share were issued and sold in the offering, which includes 937,500 shares issued upon the exercise of the underwriters option to purchase additional shares.
  • The gross proceeds to Karyopharm from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be $172.5 million.
  • RBC Capital Markets, Baird and H.C. Wainwright & Co. are acting as co-managers for the offering.

Zogenix Announces Proposed Public Offering of Common Stock

Tuesday, March 3, 2020 - 10:07pm

EMERYVILLE, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Key Points: 
  • EMERYVILLE, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.
  • Zogenix also expects to grant to the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.
  • All of the shares to be sold in the offering are to be sold by Zogenix.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

DIGITAL ALLY PRICES $2.9 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

Friday, February 28, 2020 - 3:59am

The proposed offering equates to 2,521,740 shares of the Companys common stock at a price of $1.15 per share.

Key Points: 
  • The proposed offering equates to 2,521,740 shares of the Companys common stock at a price of $1.15 per share.
  • The Company intends to use the net proceeds from this offering to fund the repayment of debt and for general corporate purposes.
  • In addition, the Company expects to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any.
  • For additional news and information please visit www.digitalallyinc.com or follow additional Digital Ally Inc. social media channels here: